JavaScript ist deaktiviert
Die JavaScript-Funktionalität Ihres Browsers ist deaktiviert. Um diese ConfTool-Funktion nutzen zu können, müssen Sie JavaScript aktivieren.
Hier finden Sie Informationen zur Aktivierung von JavaScript.
Bei Fragen oder Problemen wenden Sie sich bitte an das Organisationsteam unter aco-asso@congressorganisation.at.

AutorInnenindex

Liste aller Personen, die Beiträge in den Konferenzsitzungen vorstellen. Bitte wählen Sie einen Buchstaben aus, um die Liste aller Personen einzusehen, deren Nachname mit diesem Buchstaben beginnt. Wählen Sie die Präsentation in der rechten Spalte aus, um Zugang zu Sitzungs- und Präsentationssdetails zu erhalten.

Nach Anfangsbuchstaben auflisten: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Ö Alle AutorInnen

Listenoptionen: AutorInnen und Sitzungen · AutorInnen und Sitzungen (Kurztitel) · AutorInnen und Präsentationen | Sitzungsvorsitzende hinzufügen

AutorInnen	Organisation(en)	Titel des Beitrags
Aigner, Clemens		Synchron metastasiertes Bronchuskarzinom - gibt es Fälle, wo der der Chirurg eine Verbesserung erzielen kann? Vortragend
Aigner, Felix		Grenzen der lokalen Resektabilität beim Kolonkarzinom Vortragend
Al-Khaffaf, Daria	LK Korneuburg, Österreich	A rare case of rectum wall metastasis in pancreatic cancer - a case report
Amann, Arno		Metastasiertes Rektumkarzinom mit kurativem Therapieansatz – immer multimodal? Metachron vs synchron, BRAF mutiert? MSI? Vortragend
Augustin, Florian		Technik Lungenresektion (inkl. LK ja nein?, minimal invasiv, Laser, ...) - Vortragend
Bale, Reto		Möglichkeiten und Grenzen der stereotaktischen RFA. Vortragend
Bartsch, Rupert		Metastasiertes Mammakarzinom – Chemotherapie vs. Hormontherapie oder gibt es aus der Sicht des Onkologen auch eine Indikation zur Operation? Vortragend
Beganovic, Mirza	Klinik Oberwart, Abteilung für Allgemein-, Thorax-, Viszeral- und Gefäßchirurgie Österreich	Metachronic lung metastasis following operated PDAC of the pancreatic head. Is surgery still offering a therapeutic possibility ? Chronology of a success through an aggressive surgical treatment sequence.
Berchtold, Valeria	Universitätsklinik für Visceral-, Transplantations- und Thoraxchirurgie, Medizinische Universität Innsbruck	Minimally Invasive Esophagectomy - Clinical Implementation of a new Technique
Biebl, Matthias	Department of Surgery, Ordensklinikum Linz, Austria; Johannes Kepler University Linz, Medical Faculty, Linz, Austria; Ordensklinikum Linz GmbH, Österreich	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC Cytoreductive surgery (CRS) and hyperthermal intraperitoneal chemotherapy (HIPEC) in peritoneal metastatic colorectal cancer: 10 years of CRS and HIPEC at the Ordensklinikum Linz Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik Oligometastasierungskonzept bei Magentumoren – Leber, Lunge, Peritoneum - was macht wann wie Sinn? Vortragend Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery Metastases from other organs as rare histological findings in thyroid surgery
Burghofer, Jonathan	Laboratory for Molecular Genetic Diagnostics, Ordensklinikum Linz, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC
Cakar-Beck, Fergül	Universitätsklinik für Visceral-, Transplantations- und Thoraxchirurgie, Medizinische Universität Innsbruck	Minimally Invasive Esophagectomy - Clinical Implementation of a new Technique
Chen, Doris	Max Perutz Labs, Department of Chromosome Biology, Center for Integrative Bioinformatics Vienna, University of Vienna, Vienna, Austria	Immunological impact of Axl/TGF-beta signaling in hepatocellular carcinoma
Danhel, Lorenz	VYRAL, Linz, Austria; Department of Surgery, Ordensklinikum Linz, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC
Danhel, Lorenz	Ordensklinikum Linz GmbH, Österreich; Department of Surgery, Ordensklinikum Linz, Austria; VYRAL Linz, Austria	Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik Metastases from other organs as rare histological findings in thyroid surgery Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery
Doleschal, Bernhard		Linkes vs. Rechtes Kolon – machts einen Unterschied? Leber/Lunge vs. Peritoneum - was sollten wir wann wie angehen? Ein onkologisches Konzept. Vortragend
Doleschal, Bernhard	Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC
Eisterer, Wolfgang		Metastasierte Magentumore - von Adenokarzinom über GIST bis NET - moderne onkologische Therapie.
Emmanuel, Klaus	Department of Surgery, Paracelsus Medical University Salzburg, Salzburg, Austria; Universitätsklinik für Viszeral-, Allgemein- und Thoraxchirurgie, Salzburg, Österreich	Cytoreductive surgery (CRS) and hyperthermal intraperitoneal chemotherapy (HIPEC) in peritoneal metastatic colorectal cancer: 10 years of CRS and HIPEC at the Ordensklinikum Linz Oligometastasierungskonzept mit Resektion von Primum/Metastasen beim Ösophaguskarzinom Adeno vs. PE Ca; synchron vs. metachron. Vortragend Surgical treatment of stomach cancer in Austria
Ennemoser, Anna	Institute of Human Genetics, Medical University of Innsbruck, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer
Fritz, Antonia	Department of Surgery, Ordensklinikum Linz, Austria; VYRAL Linz, Austria	Metastases from other organs as rare histological findings in thyroid surgery Vortragend Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC
Fritz, Antonia	Ordensklinikum Linz GmbH, Österreich; VYRAL, Linz, Austria; Department of Surgery, Ordensklinikum Linz, Austria	Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery
Függer, Reinhold	Department of Surgery, Ordensklinikum Linz, Austria	The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery
Gabor, Sabine	Klinik Oberwart, Abteilung für Allgemein-, Thorax-, Viszeral- und Gefäßchirurgie Österreich	Metachronic lung metastasis following operated PDAC of the pancreatic head. Is surgery still offering a therapeutic possibility ? Chronology of a success through an aggressive surgical treatment sequence. The Pulmonary Nodule and Breast Carcinoma - A Surgical Chameleon
Gabor, Sabine	Klinik Oberwart, Österreich	Surgical Approach for Lung and Liver Metastasis One Incision, One Solution
Gal, Orsolya	LK Korneuburg, Österreich	A rare case of rectum wall metastasis in pancreatic cancer - a case report
Gehwolf, Philipp	Universitätsklinik für Visceral-, Transplantations- und Thoraxchirurgie, Medizinische Universität Innsbruck	Minimally Invasive Esophagectomy - Clinical Implementation of a new Technique
Greil, Richard		Das ductale Adenokarzinom des Pankreas ist sowieso primär eine systemische Erkrankung und wird daher in Zukunft nur mehr vom Onkologen behandelt? Kann die Bestimmung von ctDNA in der liquid biopsy in der Therapieplanung helfen? Vortragend
Grünberger, Thomas		Technik Leberresektion (inkl. Hypertrophiebehandlung, Splitting) - state of the art. Vortragend
Grünberger, Thomas	Department of Surgery, HPB Center, Viennese Health Network, Clinic Favoriten and Sigmund Freud Private University, Vienna, Austria	Immunological impact of Axl/TGF-beta signaling in hepatocellular carcinoma
Grundner, Stephan	Department of Diagnostic and Interventional Radiology, Ordensklinikum Linz, Austria	Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment
Hackl, Dominik	Department of Surgery, Ordensklinikum Linz, Austria	Metastases from other organs as rare histological findings in thyroid surgery
Havranek, Lukas	VYRAL, Linz, Austria; Department of Surgery, Ordensklinikum Linz, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC
Havranek, Lukas	Ordensklinikum Linz GmbH, Österreich; Department of Surgery, Ordensklinikum Linz, Austria; VYRAL Linz, Austria	Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik Metastases from other organs as rare histological findings in thyroid surgery Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery
Hillinger, Theresa	Center for Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria	Immunological impact of Axl/TGF-beta signaling in hepatocellular carcinoma
Hochwarter, Gerhard	Klinik Oberwart	The Pulmonary Nodule and Breast Carcinoma - A Surgical Chameleon
Hoda, Mir Alireza		Metachron metastasiertes Bronchuskarzinom - Indikationen zur chirurgischen Therapie.
Jäger, Tarkan		Technik und Indikation PIPAC
Jukic, Emina	Institute of Human Genetics, Medical University of Innsbruck, Austria	Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC
Kacerovsky-Strobl, Stephanie		Hepatale Metastasierung – wann soll/darf man resezieren? Pulmonale Metastasierung – wann soll/darf man resezieren? Vortragend
Kaczirek, Klaus		Grenzen der Resektabilität bei Lebermetastasen Vortragend
Kaddri, Abdelfattah	Klinik Oberwart, Abteilung für Allgemein-, Thorax-, Viszeral- und Gefäßchirurgie, Österreich	Is the K-ras mutation status a prognostical tool to predict metastasis formation for CRC patients??
Kienzl-Wagner, Katrin	Universitätsklinik für Visceral-, Transplantations- und Thoraxchirurgie, Medizinische Universität Innsbruck	Minimally Invasive Esophagectomy - Clinical Implementation of a new Technique
Kirchweger, Patrick	Gastrointestinal Cancer Center, Linz, Austria; Department of Surgery, Ordensklinikum Linz, Austria; Johannes Kepler University Linz, Medical Faculty, Linz, Austria; VYRAL, Linz, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Vortragend Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC Vortragend Cytoreductive surgery (CRS) and hyperthermal intraperitoneal chemotherapy (HIPEC) in peritoneal metastatic colorectal cancer: 10 years of CRS and HIPEC at the Ordensklinikum Linz Metastases from other organs as rare histological findings in thyroid surgery Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC Vortragend The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery Vortragend
Kirchweger, Patrick	Ordensklinikum Linz GmbH, Österreich	Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik
Koch, Oliver	Universitätsklinik für Viszeral-, Allgemein- und Thoraxchirurgie, Salzburg, Österreich	Ösophaguskarzinom Vortragend Surgical treatment of stomach cancer in Austria
Kratzer, Theresa	VYRAL, Linz, Austria; Department of Surgery, Ordensklinikum Linz, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC
Kratzer, Theresa	Ordensklinikum Linz GmbH, Österreich; Department of Surgery, Ordensklinikum Linz, Austria; VYRAL Linz, Austria	Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik Metastases from other organs as rare histological findings in thyroid surgery Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery
Kupferthaler, Alexander	Department of Diagnostic and Interventional Radiology, Ordensklinikum Linz, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC
Langmayr, Johannes	LK Korneuburg, Österreich	A rare case of rectum wall metastasis in pancreatic cancer - a case report
Lindenmann, Jörg		Grenzen der Resektabilität bei Lungenmetastasen. Vortragend
Linz, Vyral	VYRAL, Linz, Austria	Cytoreductive surgery (CRS) and hyperthermal intraperitoneal chemotherapy (HIPEC) in peritoneal metastatic colorectal cancer: 10 years of CRS and HIPEC at the Ordensklinikum Linz
Maio, Giovanni		Festvortrag Vortragend
Matzi, Veronika	Privatklinik Villach, Österreich	Metachronic lung metastasis following operated PDAC of the pancreatic head. Is surgery still offering a therapeutic possibility ? Chronology of a success through an aggressive surgical treatment sequence.
Mayrhofer, Lukas	Department of Surgery, Ordensklinikum Linz, Austria	The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery
Mikulits, Wolfgang	Center for Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria	Immunological impact of Axl/TGF-beta signaling in hepatocellular carcinoma
Niernberger, Thomas	Klinik Oberwart, Österreich	Surgical Approach for Lung and Liver Metastasis One Incision, One Solution
Niernberger, Thomas	Klinik Oberwart, Abteilung für Allgemein-, Thorax-, Viszeral- und Gefäßchirurgie, Österreich	Is the K-ras mutation status a prognostical tool to predict metastasis formation for CRC patients?? Metachronic lung metastasis following operated PDAC of the pancreatic head. Is surgery still offering a therapeutic possibility ? Chronology of a success through an aggressive surgical treatment sequence. The Pulmonary Nodule and Breast Carcinoma - A Surgical Chameleon
Öllinger, Robert		Multiviszerale Eingriffe und Indikation/Sinnhaftigkeit Vortragend
Oppelt, Peter	Allgemein- und Viszeralchirurgie, Kepler Universitätsklinikum Linz, Österreich	Interdisciplinary multivisceral resection in metastatic ovarian cancer
Ortmayr, Gregor	Center for Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria	Immunological impact of Axl/TGF-beta signaling in hepatocellular carcinoma
Perathoner, Alexander		Technik Peritonektomie/HIPEC state of the art Vortragend
Pichler, Martin	Klinikum Augsburg, Abteilung für Onkologie	Is the K-ras mutation status a prognostical tool to predict metastasis formation for CRC patients??
Prommegger, Rupert		Metastasiertes Schilddrüsenkarzinom: papillär, folikulär, medullär -Megaradiojod vs. Chemotherapie oder gibt es auch Indikationen für eine chirurgische Resektion? Vortragend
Puecher, Andreas	Universitätsklinik für Visceral-, Transplantations- und Thoraxchirurgie, Medizinische Universität Innsbruck	Minimally Invasive Esophagectomy - Clinical Implementation of a new Technique
Punkenhofer, Paul	Ordensklinikum Linz GmbH, Österreich	Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik Vortragend
Punkenhofer, Paul	VYRAL, Linz, Austria; Department of Surgery, Ordensklinikum Linz, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC Metastases from other organs as rare histological findings in thyroid surgery Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery
Punzengruber, Antonia	VYRAL, Linz, Austria; Department of Surgery, Ordensklinikum Linz, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC
Punzengruber, Antonia	Ordensklinikum Linz GmbH, Österreich; Department of Surgery, Ordensklinikum Linz, Austria; VYRAL Linz, Austria	Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik Metastases from other organs as rare histological findings in thyroid surgery Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery
Raab, Sandra	Allgemein- und Viszeralchirurgie, Kepler Universitätsklinikum Linz, Österreich	Interdisciplinary multivisceral resection in metastatic ovarian cancer Vortragend
Rabl, Charlotte	Universitätsklinik für Viszeral-, Allgemein- und Thoraxchirurgie, Salzburg, Österreich	Surgical treatment of stomach cancer in Austria
Reithofer, Nina	Klinik Oberwart, Abteilung für Allgemein-, Thorax-, Viszeral- und Gefäßchirurgie, Österreich	Is the K-ras mutation status a prognostical tool to predict metastasis formation for CRC patients?? The Pulmonary Nodule and Breast Carcinoma - A Surgical Chameleon Vortragend
Rezaie, Daniel	Department of Surgery, Ordensklinikum Linz, Austria; VYRAL, Linz, Austria	Cytoreductive surgery (CRS) and hyperthermal intraperitoneal chemotherapy (HIPEC) in peritoneal metastatic colorectal cancer: 10 years of CRS and HIPEC at the Ordensklinikum Linz Vortragend Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC
Rezaie, Daniel	Ordensklinikum Linz GmbH, Österreich; Department of Surgery, Ordensklinikum Linz, Austria; VYRAL Linz, Austria	Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik Metastases from other organs as rare histological findings in thyroid surgery Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery
Rohregger, Klemens	Department of Surgery, Ordensklinikum Linz, Austria	Cytoreductive surgery (CRS) and hyperthermal intraperitoneal chemotherapy (HIPEC) in peritoneal metastatic colorectal cancer: 10 years of CRS and HIPEC at the Ordensklinikum Linz Peritoneal metastasiertes CRC vorbekannt, elektiv als Zufallsbefund, in der Akutsituation: Was mache ich wann wie am besten?
Rumpold, Holger		Metastasiertes Adeno- oder Plattenepithelkarzinom - Möglichkeiten der modernen Chemo/Immuntherapie. Vortragend
Rumpold, Holger	Gastrointestinal Cancer Center, Linz, Austria; Johannes Kepler University Linz, Medical Faculty, Linz, Austria; Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC
Sauseng, Siegfried	Klinik Oberwart	The Pulmonary Nodule and Breast Carcinoma - A Surgical Chameleon Is the K-ras mutation status a prognostical tool to predict metastasis formation for CRC patients?? Vortragend Metachronic lung metastasis following operated PDAC of the pancreatic head. Is surgery still offering a therapeutic possibility ? Chronology of a success through an aggressive surgical treatment sequence. Vortragend Surgical Approach for Lung and Liver Metastasis One Incision, One Solution
Schaberl-Moser, Renate		HCC und CCC im metastasierten Stadium aus Sicht des Onkologen. Metastasiertes Bronchuskarzinom: Chemotherapie vs. PD-L1 Checkpoint Inhibitoren - state of the art. Vortragend
Schäfer, Aline	Universitätsklinik für Visceral-, Transplantations- und Thoraxchirurgie, Medizinische Universität Innsbruck	Minimally Invasive Esophagectomy - Clinical Implementation of a new Technique
Schmid, Thomas	Universitätsklinik für Visceral-, Transplantations- und Thoraxchirurgie, Medizinische Universität Innsbruck	Minimally Invasive Esophagectomy - Clinical Implementation of a new Technique
Schneeberger, Stefan		Prognoseverbesserung durch Resektion/Transplantation von Leber- und Gallenblasen/gangstumoren mit Lymphknoten/intrahepatischen vs. Fernmetastasen? Vortragend
Schober, Sarah	LK Korneuburg, Österreich	A rare case of rectum wall metastasis in pancreatic cancer - a case report Vortragend
Schuler, Pia	Center for Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria	Immunological impact of Axl/TGF-beta signaling in hepatocellular carcinoma Vortragend
Schwanzer, Erhard	LK Korneuburg, Österreich	A rare case of rectum wall metastasis in pancreatic cancer - a case report
Schwendinger, Simon	Institute of Human Genetics, Medical University of Innsbruck, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC
Schwenninger, Marie-Valerie	LK Korneuburg, Österreich	A rare case of rectum wall metastasis in pancreatic cancer - a case report
Shalamberidze, Demetre	Ordensklinikum Linz GmbH, Österreich	Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik
Shamiyeh, Andreas	Allgemein- und Viszeralchirurgie, Kepler Universitätsklinikum Linz, Österreich	Interdisciplinary multivisceral resection in metastatic ovarian cancer
Spaun, Georg	Ordensklinikum Linz GmbH, Österreich	Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik
Starlinger, Patrick	Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA	Immunological impact of Axl/TGF-beta signaling in hepatocellular carcinoma
Stift, Anton		Rektumkarzinom/Analkarzinom Vortragend
Stranzl-Lawatsch, Heidi		Oligometastasierung -aus der Sicht der Strahlentherapie Vortragend
Strobel, Oliver		Oligometastasierungskonzept beim Pankreaskarzinom – wann und wie macht was Sinn? Vortragend
Sucher, Robert		Metastasenleber – Indikationen zur Transplantation - gibt es die? Vortragend
Synek, Christof	LK Korneuburg, Österreich	A rare case of rectum wall metastasis in pancreatic cancer - a case report
Szabo, Kornel	Allgemein- und Viszeralchirurgie, Kepler Universitätsklinikum Linz, Österreich	Interdisciplinary multivisceral resection in metastatic ovarian cancer
Szilagyi, Imre	Allgemein- und Viszeralchirurgie, Kepler Universitätsklinikum Linz, Österreich	Interdisciplinary multivisceral resection in metastatic ovarian cancer
Tatalovic, Stefan	Department of Surgery, Ordensklinikum Linz, Austria; VYRAL, Linz, Austria	Circulating tumor DNA (ctDNA) dynamics predict early response to treatment in mGEC after 2 weeks of systemic treatment Vortragend Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC
Tatalovic, Stefan	Ordensklinikum Linz GmbH, Österreich; Department of Surgery, Ordensklinikum Linz, Austria; VYRAL Linz, Austria	Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik Metastases from other organs as rare histological findings in thyroid surgery Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery
Vega Palma, Matias Ignacio	Klinik Oberwart	The Pulmonary Nodule and Breast Carcinoma - A Surgical Chameleon Surgical Approach for Lung and Liver Metastasis One Incision, One Solution Vortragend
Vega-Palma, Matias Ignacio	Klinik Oberwart, Abteilung für Allgemein-, Thorax-, Viszeral- und Gefäßchirurgie, Österreich	Is the K-ras mutation status a prognostical tool to predict metastasis formation for CRC patients?? Metachronic lung metastasis following operated PDAC of the pancreatic head. Is surgery still offering a therapeutic possibility ? Chronology of a success through an aggressive surgical treatment sequence.
Wallner, Eva	Universitätsklinik für Viszeral-, Allgemein- und Thoraxchirurgie, Salzburg, Österreich	Surgical treatment of stomach cancer in Austria Vortragend
Weisser, Elena	Ordensklinikum Linz GmbH, Österreich	Endoskopische Gastroenterostomie mit Hilfe von LAMS – Entwicklung zur standardisierten Technik
Weitzendorfer, Michael	Universitätsklinik für Viszeral-, Allgemein- und Thoraxchirurgie, Salzburg, Österreich	Surgical treatment of stomach cancer in Austria
Wundsam, Helwig	Department of Surgery, Ordensklinikum Linz, Austria	Achieving clinical applicability for circulating tumor DNA (ctDNA) as biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer Correlation of ctDNA with actual volumetric tumor burden and outcome in mCRC Revolutionizing systemic treatment evaluation in GI cancer care: ctDNA as a unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for GEC, PC and CRC The prognostic impact of the recurrence distribution pattern following curative intended pancreatic cancer surgery
Wykypiel, Heinz	Universitätsklinik für Visceral-, Transplantations- und Thoraxchirurgie, Medizinische Universität Innsbruck	Minimally Invasive Esophagectomy - Clinical Implementation of a new Technique Vortragend
Zitt, Matthias		Grenzen der lokalen Resektabilität beim Rektumkarzinom. Vortragend

Mobile Ansicht Druckansicht

Impressum · Kontaktadresse:

aco-asso{at}congressorganisation dot

Datenschutzerklärung · Veranstaltung: ACO ASSO Jahrestagung 2023

39. Jahrestagung der ACO ASSO

“Metastasenchirurgie im Grenzbereich”

5.-7. Oktober 2023 | Scalaria St. Wolfgang, Österreich

AutorInnenindex